Drug Type Small molecule drug |
Synonyms GRC 15300, GRC 17173, GRC-17173 + [3] |
Target |
Mechanism TRPV3 antagonists(Transient receptor potential cation channel subfamily V member 3 channel antagonists) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuralgia | Phase 2 | US | 01 Mar 2012 | |
Neuralgia | Phase 2 | CZ | 01 Mar 2012 | |
Neuralgia | Phase 2 | HU | 01 Mar 2012 | |
Neuralgia | Phase 2 | PL | 01 Mar 2012 | |
Neuralgia | Phase 2 | RU | 01 Mar 2012 | |
Neuralgia | Phase 2 | SK | 01 Mar 2012 | |
Neuralgia | Phase 2 | UA | 01 Mar 2012 | |
Musculoskeletal Pain | Phase 1 | GB | - | |
Skin Diseases | Phase 1 | IN | - | |
Urinary Incontinence | Preclinical | IN | - |